WASHINGTON (dpa-AFX) - Perrigo Company plc (PRGO) said that it has settled its Hatch-Waxman litigation relating to Nascobal Nasal Spray brought by Endo Pharmaceuticals Inc. It did not disclose terms of the settlement.
According to IQVIA, annual market sales for the 12-months ending June 2019 were $90 million.
Perrigo Executive Vice President and President Rx Pharmaceuticals Sharon Kochan said, '.... Our R&D, operations and legal teams continue to work diligently and relentlessly to introduce new generic products that provide savings to patients and healthcare systems.'
Copyright RTT News/dpa-AFX